Cloning and characterization of the murine claudin-5 promoter

Molecular and Cellular Endocrinology

Volumn 298, Issue 1-2, 2009, Pages 19-24

  Burek, Malgorzata ^a   Förster, Carola Y ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Claudin; Cytokine; Endothelial cell; Glucocorticoid; Promoter; Tight junction

Indexed keywords

CLAUDIN 5; DEXAMETHASONE; GLUCOCORTICOID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR SP1; TRANSCRIPTION FACTOR SP2; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; E BOX ELEMENT; HUMAN; HUMAN CELL; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; TATA BOX;

ANIMALS; BASE SEQUENCE; CELLS, CULTURED; CLONING, MOLECULAR; DEXAMETHASONE; GENE DELETION; GENES, REPORTER; HUMANS; MEMBRANE PROTEINS; MICE; MOLECULAR SEQUENCE DATA; ORGAN SPECIFICITY; PROMOTER REGIONS, GENETIC; TISSUE DISTRIBUTION; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 57749170241     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2008.09.041     Document Type: Article

References (46)

1. Barnes P.J., and Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med. 336 (1997) 1066-1071
2. Batlle E., Sancho E., Franci C., Dominguez D., Monfar M., Baulida J., and Garcia De Herreros A. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat. Cell Biol. 2 (2000) 84-89
3. Beato M. Gene regulation by steroid hormones. Cell 56 (1989) 335-344
4. Blecharz K.G., Drenckhahn D., and Förster C.Y. Glucocorticoids increase VE-cadherin expression and cause cytoskeletal rearrangements in murine brain endothelial cEND cells. J. Cereb. Blood Flow Metab. (2008)
5. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
6. Calabria A.R., Weidenfeller C., Jones A.R., de Vries H.E., and Shusta E.V. Puromycin-purified rat brain microvascular endothelial cell cultures exhibit improved barrier properties in response to glucocorticoid induction. J. Neurochem. 97 (2006) 922-933
7. Cano A., Perez-Moreno M.A., Rodrigo I., Locascio A., Blanco M.J., del Barrio M.G., Portillo F., and Nieto M.A. The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat. Cell Biol. 2 (2000) 76-83
8. Daugherty B.L., Mateescu M., Patel A.S., Wade K., Kimura S., Gonzales L.W., Guttentag S., Ballard P.L., and Koval M. Developmental regulation of claudin localization by fetal alveolar epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 287 (2004) L1266-L1273
9. Defazio G., Trojano M., Ribatti D., Nico B., Giorelli M., De Salvia R., Russo G., Roncali L., and Livrea P. ICAM 1 expression and fluid phase endocytosis of cultured brain microvascular endothelial cells following exposure to interferon beta-1a and TNFalpha. J. Neuroimmunol. 88 (1998) 13-20
10. D'Souza T., Agarwal R., and Morin P.J. Phosphorylation of claudin-3 at threonine 192 by cAMP-dependent protein kinase regulates tight junction barrier function in ovarian cancer cells. J. Biol. Chem. 280 (2005) 26233-26240
11. Fontijn R.D., Volger O.L., Fledderus J.O., Reijerkerk A., de Vries H.E., and Horrevoets A.J. SOX-18 controls endothelial-specific claudin-5 gene expression and barrier function. Am. J. Physiol. Heart Circ. Physiol. 294 (2008) H891-900
12. Förster C., Burek M., Romero I.A., Weksler B., Couraud P.O., and Drenckhahn D. Differential effects of hydrocortisone and TNF{alpha} on tight junction proteins in an in vitro model of the human blood-brain barrier. J. Physiol. (2008)
13. Förster C., Silwedel C., Golenhofen N., Burek M., Kietz S., Mankertz J., and Drenckhahn D. Occludin as direct target for glucocorticoid-induced improvement of blood-brain barrier properties in a murine in vitro system. J. Physiol. 565 Pt. 2 (2005) 475-486
14. Förster C., Waschke J., Burek M., Leers J., and Drenckhahn D. Glucocorticoid effects on mouse microvascular endothelial barrier permeability are brain specific. J. Physiol. 573 (2006) 413-425
15. Förster C., Kietz S., Kahles T., and Drenckhahn D. Dexamethasone induces the expression of metalloproteinase inhibitor TIMP-1 in the murine cerebral vascular endothelial cell line cEND. J. Physiol. 580 3 (2007) 937-949
16. Fujibe M., Chiba H., Kojima T., Soma T., Wada T., Yamashita T., and Sawada N. Thr203 of claudin-1, a putative phosphorylation site for MAP kinase, is required to promote the barrier function of tight junctions. Exp. Cell Res. 295 (2004) 36-47
17. Golenhofen N., Ness W., Wawrousek E.F., and Drenckhahn D. Expression and induction of the stress protein alpha-B-crystallin in vascular endothelial cells. Histochem. Cell Biol. 117 (2002) 203-209
18. Gonzales L.W., Guttentag S.H., Wade K.C., Postle A.D., and Ballard P.L. Differentiation of human pulmonary type II cells in vitro by glucocorticoid plus cAMP. Am. J. Physiol. Lung Cell Mol. Physiol. 283 (2002) L940-L951
19. Hermanns M.I., Unger R.E., Kehe K., Peters K., and Kirkpatrick C.J. Lung epithelial cell lines in coculture with human pulmonary microvascular endothelial cells: development of an alveolo-capillary barrier in vitro. Lab. Invest. 84 (2004) 736-752
20. Hoheisel D., Nitz T., Franke H., Wegener J., Hakvoort A., Tilling T., and Galla H.J. Hydrocortisone reinforces the blood-brain barrier properties in a serum free cell culture system. Biochem. Biophys. Res. Commun. 244 (1998) 312-316
21. Ikenouchi J., Matsuda M., Furuse M., and Tsukita S. Regulation of tight junctions during the epithelium-mesenchyme transition: direct repression of the gene expression of claudins/occludin by snail. J. Cell Sci. 116 (2003) 1959-1967
22. Kallmann B.A., Hummel V., Lindenlaub T., Ruprecht K., Toyka K.V., and Rieckmann P. Cytokine-induced modulation of cellular adhesion to human cerebral endothelial cells is mediated by soluble vascular cell adhesion molecule-1. Brain 123 Pt 4 (2000) 687-697
23. Korner H., and Sedgwick J.D. Tumour necrosis factor and lymphotoxin: molecular aspects and role in tissue-specific autoimmunity. Immunol. Cell Biol. 74 (1996) 465-472
24. Liebner S., Kniesel U., Kalbacher H., and Wolburg H. Correlation of tight junction morphology with the expression of tight junction proteins in blood-brain barrier endothelial cells. Eur. J. Cell Biol. 79 (2000) 707-717
25. Lorenz W.W., McCann R.O., Longiaru M., and Cormier M.J. Isolation and expression of a cDNA encoding Renilla reniformis luciferase. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 4438-4442
26. Lui W.Y., Wong E.W., Guan Y., and Lee W.M. Dual transcriptional control of claudin-11 via an overlapping GATA/NF-Y motif: positive regulation through the interaction of GATA, NF-YA, and CREB and negative regulation through the interaction of Smad, HDAC1, and mSin3A. J. Cell Physiol. 211 (2007) 638-648
27. Mankertz J., Tavalali S., Schmitz H., Mankertz A., Riecken E.O., Fromm M., and Schulzke J.D. Expression from the human occludin promoter is affected by tumor necrosis factor alpha and interferon gamma. J. Cell Sci. 113 Pt 11 (2000) 2085-2090
28. Martinez-Estrada O.M., Culleres A., Soriano F.X., Peinado H., Bolos V., Martinez F.O., Reina M., Cano A., Fabre M., and Vilaro S. The transcription factors slug and snail act as repressors of claudin-1 expression in epithelial cells. Biochem. J. 394 (2006) 449-457
29. Matter K., and Balda M.S. Holey barrier: claudins and the regulation of brain endothelial permeability. J. Cell Biol. 161 (2003) 459-460
30. Miwa N., Furuse M., Tsukita S., Niikawa N., Nakamura Y., and Furukawa Y. Involvement of claudin-1 in the beta-catenin/Tcf signaling pathway and its frequent upregulation in human colorectal cancers. Oncol. Res. 12 (2001) 469-476
31. Morita K., Furuse M., Fujimoto K., and Tsukita S. Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 511-516
32. Morita K., Sasaki H., Furuse M., and Tsukita S. Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J. Cell Biol. 147 (1999) 185-194
33. Muller D.M., Pender M.P., and Greer J.M. Chemokines and chemokine receptors: potential therapeutic targets in multiple sclerosis. Curr. Drug Targets Inflamm. Allergy 3 (2004) 279-290
34. Niimi T., Nagashima K., Ward J.M., Minoo P., Zimonjic D.B., Popescu N.C., and Kimura S. Claudin-18, a novel downstream target gene for the T/EBP/NKX2.1 homeodomain transcription factor, encodes lung- and stomach-specific isoforms through alternative splicing. Mol. Cell Biol. 21 (2001) 7380-7390
35. Nitta T., Hata M., Gotoh S., Seo Y., Sasaki H., Hashimoto N., Furuse M., and Tsukita S. Size-selective loosening of the blood-brain barrier in claudin-5-deficient mice. J. Cell Biol. 161 (2003) 653-660
36. Pober J.S. Activation and injury of endothelial cells by cytokines. Pathol. Biol. (Paris) 46 (1998) 159-163
37. Romero I.A., Radewicz K., Jubin E., Michel C.C., Greenwood J., Couraud P.O., and Adamson P. Changes in cytoskeletal and tight junctional proteins correlate with decreased permeability induced by dexamethasone in cultured rat brain endothelial cells. Neurosci. Lett. 344 (2003) 112-116
38. Sakaguchi T., Gu X., Golden H.M., Suh E., Rhoads D.B., and Reinecker H.C. Cloning of the human claudin-2 5′-flanking region revealed a TATA-less promoter with conserved binding sites in mouse and human for caudal-related homeodomain proteins and hepatocyte nuclear factor-1alpha. J. Biol. Chem. 277 (2002) 21361-21370
39. Silwedel C., and Förster C. Differential susceptibility of cerebral and cerebellar murine brain microvascular endothelial cells to loss of barrier properties in response to inflammatory stimuli. J. Neuroimmunol. 179 (2006) 37-45
40. Sirotkin H., Morrow B., Saint-Jore B., Puech A., Das Gupta R., Patanjali S.R., Skoultchi A., Weissman S.M., and Kucherlapati R. Identification, characterization, and precise mapping of a human gene encoding a novel membrane-spanning protein from the 22q11 region deleted in velo-cardio-facial syndrome. Genomics 42 (1997) 245-251
41. Steinke A., Meier-Stiegen S., Drenckhahn D., and Asan E. Molecular composition of tight and adherens junctions in the rat olfactory epithelium and fila. Histochem. Cell Biol. (2008)
42. Tsukita S., Furuse M., and Itoh M. Multifunctional strands in tight junctions. Nat. Rev. Mol. Cell Biol. 2 (2001) 285-293
43. Weber F., and Rieckmann P. Pathogenesis and therapy of multiple sclerosis. The role of cytokines. Nervenarzt 66 (1995) 150-155
44. Weksler B.B., Subileau E.A., Perriere N., Charneau P., Holloway K., Leveque M., Tricoire-Leignel H., Nicotra A., Bourdoulous S., Turowski P., Male D.K., Roux F., Greenwood J., Romero I.A., and Couraud P.O. Blood-brain barrier-specific properties of a human adult brain endothelial cell line. FASEB J. 19 (2005) 1872-1874
45. Wolburg H., Wolburg-Buchholz K., Kraus J., Rascher-Eggstein G., Liebner S., Hamm S., Duffner F., Grote E.H., Risau W., and Engelhardt B. Localization of claudin-3 in tight junctions of the blood-brain barrier is selectively lost during experimental autoimmune encephalomyelitis and human glioblastoma multiforme. Acta Neuropathol. 105 (2003) 586-592
46. Wong D., Prameya R., and Dorovini-Zis K. In vitro adhesion and migration of T lymphocytes across monolayers of human brain microvessel endothelial cells: regulation by ICAM-1, VCAM-1, E-selectin and PECAM-1. J. Neuropathol. Exp. Neurol. 58 (1999) 138-152